Type 2 diabetes
Conditions
Interventions
25mg of 50mg sitagliptin
Sponsors
Hyogo College of Medicine, Division of Diabetes, Endocrinology & Metabolism
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) The type 2 diabetes patient whom blood sugar control is inadequate for 2) 20 years old or older 3) Sex no object 4) Outpatient 5) The patient that a written agreement was provided
Exclusion criteria
Exclusion criteria: 1)ketotic diabetic coma severe within the past six months or patient with the previous comatose past 2)Severe infectious disease, before and after operation, patient with a serious injury 3)pregnant woman or a woman with the possibility of the pregnancy and the patient whom I am nursing 4)Patient(more than less than creatinine clearance 50ml/min, serum creatinine man 1.5mg/dL more than woman 1.3mg/dL) having renal function disorder more than medium degree 5)Patient during insulin prescription 6)Patient during A-GI,drugs prescription 7)It is a patient with a history of the past of hypersensitivity for an ingredient of the study medicine 8)The patient whom the chief physician assumed inappropriateness for study articipation in planning from medical grounds
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of HbA1c | — |
Secondary
| Measure | Time frame |
|---|---|
| The change in fasting blood glucose Glycoalbumin (GA) The weight Glucagon Insulin C-peptide Intact pro insulin(insulin/insulin ratio ) | — |
Countries
Japan
Contacts
Public ContactJyun-ichiro Miyagawa
Hyogo College of Medicine Division of Diabetes, Endocrinology & Metabolism
Outcome results
None listed